People with Down syndrome have 47 chromosomes instead of the usual 46, with the extra chromosome being a third copy of chromosome 21. That is why the condition’s clinical name is trisomy 21. But that headline number of 47 is slightly misleading, because not every person with Down syndrome carries a full extra chromosome in every cell, and the different ways that extra genetic material ends up in the body affect everything from how the condition is diagnosed to how severe the symptoms are.
Why 47 Instead of 46
Human cells normally contain 23 pairs of chromosomes, one set inherited from each parent, totaling 46. Down syndrome occurs when something goes wrong during the formation of egg or sperm cells, a process called meiosis. The pair of chromosome 21s that should split apart and go to separate cells instead sticks together and travels into the same cell. When that egg or sperm is fertilized, the resulting embryo ends up with three copies of chromosome 21 rather than two. This error in chromosome separation is the most common chromosomal abnormality in live births.1The USA Journals TAJAS. Conventional Karyotyping in Down Syndrome: Diagnostic Relevance in the Molecular Era
The separation failure is strongly linked to maternal age, though researchers have had limited success pinning down other risk factors beyond that well-established connection.2PubMed Central. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations The extra chromosome 21 doesn’t just sit there inert. Having three copies instead of two means the cell produces roughly 50 percent more of many of the proteins encoded by genes on that chromosome, and this gene-dosage imbalance is thought to be the root cause of the developmental differences seen in Down syndrome.3PubMed Central. Gene-dosage effects in Down syndrome and trisomic mouse models
Three Genetic Types, Not Just One
When people say “47 chromosomes,” they are usually describing the most common form of Down syndrome, called complete or free trisomy 21. In this form, every cell in the body carries three full copies of chromosome 21. That accounts for roughly 90 to 95 percent of all cases.4PubMed Central. Trisomy 21 and Assisted Reproductive Technologies: A review But two other forms exist, and they change the chromosome count and the clinical picture in important ways.
In translocation Down syndrome, which makes up about 1 to 5 percent of cases, the extra chromosome 21 material is physically attached to another chromosome, often chromosome 14. A person with translocation Down syndrome may have 46 chromosomes by count, not 47, yet still carry three copies’ worth of chromosome 21 genes.5PubMed Central. Robertsonian translocation T (21; 21) in a female born to normal parents: a case report This distinction matters because translocation Down syndrome is sometimes inherited from a parent who carries the rearrangement but shows no symptoms. When a translocation involves both copies of chromosome 21 fused together, as in the rare t(21;21) type, the parent who carries it has a 100 percent chance of passing Down syndrome to their children.
The third type is mosaic Down syndrome, found in about 1.4 to 1.9 percent of newborns with the condition.4PubMed Central. Trisomy 21 and Assisted Reproductive Technologies: A review In mosaicism, some cells have the typical 46 chromosomes and others have 47. The separation error happens after fertilization, during the early rounds of cell division, so only some cell lines are affected. People with mosaic Down syndrome sometimes have milder features, though the severity varies widely depending on which tissues carry the extra chromosome and what proportion of cells are trisomic.
There is also an extremely rare variant called partial trisomy 21, in which only a segment of chromosome 21 is duplicated rather than the entire chromosome. Whether partial trisomy produces features of Down syndrome depends on which portion of chromosome 21 is duplicated. Researchers have identified a stretch on chromosome 21 sometimes called the Down syndrome critical region, and duplication of that area tends to produce more recognizable features of the condition.6PubMed Central. Structural Characterization of the Highly Restricted Down Syndrome Critical Region on 21q22.13: New KCNJ6 and DSCR4 Transcript Isoforms
Why the Extra Chromosome Almost Always Comes From the Mother
In about 95 percent of cases, the extra chromosome 21 originates from the mother’s egg cell, not the father’s sperm.7PubMed. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms The father’s contribution accounts for fewer than 10 percent of cases.8PubMed Central. On the paternal origin of trisomy 21 Down syndrome This lopsided ratio has a biological explanation rooted in how egg cells are made.
Women are born with all the egg cells they will ever have, and those cells sit suspended partway through meiosis for decades. The structures that hold paired chromosomes together during that long pause rely on a protein complex called cohesin. Over the years, cohesin gradually degrades. By the time a woman is in her late thirties or forties, the molecular glue keeping chromosome pairs aligned has weakened substantially.9PubMed Central. Chromosome cohesion decreases in human eggs with advanced maternal age Studies of human eggs show that the physical distance between paired chromosome structures increases with a woman’s age, confirming the weakening of cohesion, and that in older women’s eggs the pairs can even fall apart prematurely.10PubMed Central. Meiosis and maternal aging: insights from aneuploid oocytes and trisomy births
Sperm cells, by contrast, are produced continuously from puberty onward, so they don’t spend years in a suspended state. That difference in cellular biology is the main reason chromosome separation errors are far more common in eggs than in sperm, and it explains the well-known link between advanced maternal age and Down syndrome risk.
What the Extra Genetic Material Does to the Body
Chromosome 21 is the smallest human chromosome, carrying a few hundred genes. Having an extra copy broadly increases the output of those genes, and that modest increase in protein production ripples through development in ways that affect the heart, brain, immune system, and other organs.
Congenital heart defects are among the most medically significant consequences. About 40 percent of infants with Down syndrome are born with some form of heart defect, compared to roughly 0.3 percent of children with a typical chromosome count.11PubMed Central. Down Syndrome with Complete Atrioventricular Septal Defect, Hypertrophic Cardiomyopathy, and Pulmonary Vein Stenosis The types of heart defects seen in Down syndrome tend to involve abnormal formation of the walls between the heart’s chambers. Surgical repair of these defects in infancy has been one of the biggest contributors to improved life expectancy for people with Down syndrome over the past several decades.
The extra chromosome also has a distinct relationship with certain blood cancers. Children with Down syndrome are predisposed to a form of leukemia called acute megakaryoblastic leukemia, and many newborns with the condition develop a temporary overproduction of certain blood cells known as transient abnormal myelopoiesis. Both of these are driven by an interplay between the extra chromosome 21 and mutations in a gene called GATA1, which controls the development of blood cells.12PubMed Central. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update The transient condition often resolves on its own, but a fraction of affected children go on to develop full leukemia, making close monitoring in infancy important.13PubMed. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia
The Alzheimer’s Connection
One of the most studied consequences of the extra chromosome 21 is its link to early-onset Alzheimer’s disease. Chromosome 21 carries the gene for amyloid precursor protein, or APP. When three copies of APP are present, the brain produces more of the amyloid-beta protein that accumulates as plaques in Alzheimer’s disease. People with Down syndrome have a greatly elevated risk of developing Alzheimer’s pathology, and brain changes characteristic of the disease can begin appearing by a person’s thirties or forties.14Scientific Reports. Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
How central is APP to this risk? Strong evidence comes from rare individuals with partial trisomy 21 who have the extra chromosome 21 material but not the extra copy of APP. These people do not develop Alzheimer’s disease, confirming that the third copy of APP, not just having extra chromosome 21 genes in general, is the critical factor.15PubMed Central. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP Laboratory experiments using stem cells from people with Down syndrome have refined this further, showing that the extra APP copy drives increased amyloid-beta production and an altered ratio of harmful to benign forms of the protein, but that some other features of Alzheimer’s, particularly changes to another protein called tau, appear to be driven by different factors.16Stem Cell Reports. The Impact of APP on Alzheimer-like Pathogenesis and Gene Expression in Down Syndrome iPSC-Derived Neurons
A Curious Cancer Paradox
While the extra chromosome raises the risk of certain blood cancers, the relationship with solid tumors goes in the opposite direction. People with Down syndrome have lower rates of many common solid cancers than the general population. Researchers believe that some of the genes on chromosome 21, when overexpressed due to the extra copy, have a protective effect against tumor growth.17Nature. Down syndrome This is one of the more counterintuitive findings in Down syndrome research: the same genetic imbalance that causes so many developmental problems may also confer a degree of protection against a major category of disease. Understanding which genes on chromosome 21 are responsible is an active area of study, because if researchers can identify those protective mechanisms, they could potentially be harnessed for cancer treatment in the broader population.
How Prenatal Screening Detects the Extra Chromosome
Modern prenatal screening has made it possible to detect trisomy 21 well before birth. The most widely available method today is cell-free DNA screening, which analyzes tiny fragments of fetal DNA circulating in the pregnant person’s blood. This test can flag an elevated amount of chromosome 21 material, suggesting that the fetus may have three copies. Because it is a screening test rather than a diagnostic one, a positive result is typically followed up with a definitive procedure like amniocentesis or chorionic villus sampling, which collects fetal cells and allows a direct count of chromosomes.18American Journal of Obstetrics and Gynecology. Performance of cell-free DNA screening for aneuploidy in low-risk pregnancies
After birth, confirmation typically comes from a standard chromosome analysis called a karyotype, which produces an image of all 46 (or 47) chromosomes arranged by size and shape. The karyotype remains the gold-standard method for distinguishing between complete trisomy, translocation, and mosaic forms, which matters for genetic counseling about recurrence risk in future pregnancies.1The USA Journals TAJAS. Conventional Karyotyping in Down Syndrome: Diagnostic Relevance in the Molecular Era
Data from large national screening programs illustrate how detection has changed over time. In one study covering more than 3.2 million pregnancies, the prenatal detection rate for Down syndrome rose from 18 percent in 1999 to 70 percent in 2021. Over the same period, the underlying prevalence of Down syndrome pregnancies actually increased, from about 0.165 percent to 0.251 percent, driven largely by a trend toward childbearing at older ages. Yet the rate of live births with Down syndrome remained stable at around 0.106 percent, because the proportion of pregnancies terminated after a prenatal diagnosis rose from 20 to 55 percent.19Acta Obstetricia et Gynecologica Scandinavica. Impact of National Screening Programs on Down syndrome prevalence and outcomes These numbers highlight a tension that has grown alongside screening technology: rising maternal age increases the biological incidence of trisomy 21, while improved detection gives prospective parents earlier information and earlier decisions.
Can the Extra Chromosome Be Silenced?
One of the more intriguing lines of research aims not to remove the extra chromosome but to switch it off. The idea borrows from a natural process the body already uses: in every female cell, one of the two X chromosomes is silenced to prevent a double dose of X-linked genes. The molecule that does this job, called XIST RNA, coats the chromosome and shuts down most of its gene activity.
Researchers have inserted the gene for XIST into the extra chromosome 21 in cells taken from people with Down syndrome and grown in the lab. The results are striking. In neural stem cells, the XIST molecule was able to trigger chromosome-wide silencing of the extra chromosome 21, and the treated cells showed improved neuronal development compared to untreated trisomic cells.20PubMed Central. Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation Similar experiments in blood-cell models showed that trisomy silencing could normalize some of the blood-cell abnormalities characteristic of Down syndrome.21Nature Communications. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro
This work remains firmly in the laboratory stage. Delivering XIST to every cell in a living person’s body, particularly to brain cells after birth, is far beyond current capabilities. But the approach has proven valuable as a research tool, allowing scientists to compare trisomic and corrected cells side by side to tease apart which features of Down syndrome are directly caused by the extra chromosome’s gene activity and which arise from secondary or developmental effects that cannot be reversed after the fact.
Down Syndrome in Other Species
Humans are not the only primates that can have a trisomy resembling Down syndrome. Chimpanzees share a chromosome that is essentially the equivalent of human chromosome 21, labeled chromosome 22 in the chimpanzee genome. Cases of trisomy 22 have been documented in captive chimpanzees, producing features that parallel those seen in human Down syndrome: slowed growth, reduced muscle tone, congenital abnormalities, and developmental delays.22PubMed. Autosomal trisomy in a chimpanzee: resemblance to Down’s syndrome The first such case was described in 1969, and additional cases have been confirmed more recently using modern genetic testing to verify the extra chromosome.23PubMed. Chimpanzee Down syndrome: a case study of trisomy 22 in a captive chimpanzee
These cases are rare, likely because affected animals in the wild face strong survival pressures. But they offer researchers a natural comparison point for understanding how trisomy of this particular set of genes affects development across species, reinforcing the idea that the consequences of the extra chromosome are deeply tied to specific genes on it rather than being a general effect of having any extra chromosome at all. Other trisomies in humans, such as trisomy 13 and trisomy 18, produce very different and generally far more severe outcomes, which underscores that the particular genes on chromosome 21, and the body’s relative tolerance for their overexpression, are what shape Down syndrome’s specific pattern of features.